Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
GLI2 | hg38_v1_chr2_+_120735848_120735899 | -0.30 | 9.1e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr11_+_124739927 Show fit | 2.59 |
ENST00000284292.11
ENST00000412681.2 |
neurogranin |
|
chr17_-_7114813 Show fit | 2.57 |
ENST00000254850.11
|
asialoglycoprotein receptor 2 |
|
chr17_-_7114648 Show fit | 2.57 |
ENST00000355035.9
|
asialoglycoprotein receptor 2 |
|
chrY_+_2841594 Show fit | 2.49 |
ENST00000250784.13
|
ribosomal protein S4 Y-linked 1 |
|
chr17_-_7114240 Show fit | 2.40 |
ENST00000446679.6
|
asialoglycoprotein receptor 2 |
|
chr3_+_32951636 Show fit | 2.27 |
ENST00000330953.6
|
C-C motif chemokine receptor 4 |
|
chr14_-_94390667 Show fit | 2.27 |
ENST00000557492.5
ENST00000355814.8 ENST00000437397.5 ENST00000448921.5 ENST00000393088.8 |
serpin family A member 1 |
|
chr14_-_94390650 Show fit | 2.22 |
ENST00000449399.7
ENST00000404814.8 |
serpin family A member 1 |
|
chr14_-_94390614 Show fit | 2.21 |
ENST00000553327.5
ENST00000556955.5 ENST00000557118.5 ENST00000440909.5 |
serpin family A member 1 |
|
chr7_-_954666 Show fit | 2.21 |
ENST00000265846.10
ENST00000649206.1 |
ArfGAP with dual PH domains 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 8.3 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 7.4 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.2 | 5.1 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.0 | 4.8 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.5 | 4.2 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
0.1 | 4.2 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 3.5 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.8 | 3.2 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
0.0 | 2.6 | GO:0006968 | cellular defense response(GO:0006968) |
0.8 | 2.4 | GO:0045957 | regulation of complement activation, alternative pathway(GO:0030451) negative regulation of complement activation, alternative pathway(GO:0045957) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 9.4 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 9.0 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.2 | 7.8 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.2 | 7.2 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 4.1 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 3.9 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 2.8 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.3 | 2.7 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.2 | 2.6 | GO:0044327 | dendritic spine head(GO:0044327) |
0.0 | 2.5 | GO:0048786 | presynaptic active zone(GO:0048786) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 8.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.9 | 7.5 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.4 | 4.5 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.5 | 4.2 | GO:0032396 | inhibitory MHC class I receptor activity(GO:0032396) |
0.0 | 3.9 | GO:0019843 | rRNA binding(GO:0019843) |
0.2 | 3.7 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.3 | 3.5 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.2 | 3.5 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.0 | 3.5 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.2 | 3.3 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 8.6 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 4.6 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.0 | 4.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 4.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 3.8 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 2.2 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 2.0 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 1.8 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 1.8 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 1.7 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 9.4 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 6.6 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 6.0 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 5.4 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 4.2 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 3.8 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.2 | 3.4 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 2.9 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 2.9 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 2.7 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |